Anne Kehely
Eli Lilly (United Kingdom)(GB)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Neuropeptides and Animal Physiology, Diabetes, Cardiovascular Risks, and Lipoproteins, Migraine and Headache Studies, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with Type 2 diabetes mellitus(1998)129 cited
- → Efficacy and Tolerability of an Individualized Dosing Regimen for Adult Growth Hormone Replacement Therapy in Comparison with Fixed Body Weight-Based Dosing(2004)54 cited
- → Short-Term Safety and Efficacy of Human GH Replacement Therapy in 595 Adults with GH Deficiency: A Comparison of Two Dosage Algorithms(2002)41 cited
- → Neurosecretion of arginine vasopressin by an olfactory neuroblastoma causing reversible syndrome of antidiuresis(1986)41 cited
- → Hyperkalaemia in diabetes: prevalence and associations(1995)40 cited
- → Normal Levels of Lipoproteins including Lipoprotein(a) after Liver–heart Transplantation in a Patient with Homozygous Familial Hypercholesterolaemia(1992)33 cited
- → Abdominal Migraine as a Cause of Vomiting in Children:(1995)29 cited
- → A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies(1988)26 cited
- → Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients(1992)23 cited
- → Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia(1995)18 cited